WGRX (Wellgistics Health) ROE % Adjusted to Book Value: 0.00% (As of Mar. 2026)


What is Wellgistics Health ROE % Adjusted to Book Value?

Wellgistics Health WGRX -2.93% ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. The stock has 6 warning signs investors should review.

Wellgistics Health's ROE % for the quarter that ended in Mar. 2026 was 0.00%. Wellgistics Health's PB Ratio for the quarter that ended in Mar. 2026 was N/A. Wellgistics Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was N/A.

Wellgistics Health ROE % Adjusted to Book Value Related Terms

Wellgistics Health ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Wellgistics Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wellgistics Health ROE % Adjusted to Book Value Chart

Wellgistics Health Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00

Wellgistics Health Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.03 -14.68 -305.16 0.00 0.00

WGRX vs HEWA, BLMH, PMHS: ROE % Adjusted to Book Value Comparison

For the Pharmaceutical Retailers subindustry, Wellgistics Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wellgistics Health ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Wellgistics Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Wellgistics Health's ROE % Adjusted to Book Value falls into.


Wellgistics Health ROE % Adjusted to Book Value Calculation

Wellgistics Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Wellgistics Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Wellgistics Health (WGRX) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Wellgistics Health and its competitors.
Is Wellgistics Health's ROE % Adjusted to Book Value too high?
Wellgistics Health's current ROE % Adjusted to Book Value is 0.00%.
How does Wellgistics Health's ROE % Adjusted to Book Value compare to HEWA and BLMH?
Wellgistics Health's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Wellgistics Health and its competitors. Wellgistics Health's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellgistics Health stock overvalued right now?
Wellgistics Health (WGRX) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Wellgistics Health (WGRX), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wellgistics Health Business Description

Address 3000 Bayport Drive, Suite 950, Tampa, FL, USA, 33607
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.